A university in Russia tested the world’s first COVID 19 vaccine successfully. Russia’s university named Gamaliel institute of epidemiology and microbiology began the clinical trials for testing the vaccine on 18th June. It was tested on volunteers at the Sechenov First Moscow State Medical University. This information was confirmed by the director of the Institute for translational medicine and biotechnology, Mr Vadim Tarasov. He further went on to say that the first group of volunteers would be discharged on the Wednesday of the second of July.

The director of the institute of medical parasitology, tropical and vector-borne diseases at Sechenov University, Mr Alexander Lukashev, stated that the objective of the study conducted was to the vaccines is safe for human health. He further said that the objective was successfully achieved.

“The safety of the vaccine is confirmed. It corresponds to the safety of those vaccines that are currently on the market,” Lukashev told Sputnik.

The further vaccine development plan is already being determined by the developer’s strategy, including the complexity of the epidemiological situation with the virus and the possibility of scaling up production, Lukashev added.

“Sechenov University in a pandemic situation acted not only as an educational institution but also as a scientific and technological research centre that is able to participate in the creation of such important and complex products as drugs … We worked with this vaccine, starting with preclinical studies and protocol development, and clinical trials are currently underway,” Tarasov noted.

After over six months of novel coronavirus outbreak, which has infected more than 12 million people and killed over 500,000 all over the world, the clinical trials of the purported world’s first coronavirus vaccine have been successfully completed.

While over 7 million virus-infected people have recovered so far, scientists and other healthcare systems worldwide are trying to upgrade the production and development of a potential Covid-19 vaccine as soon as possible.

Gilead Sciences, Oxford University’s researchers and American biotech company Moderna are at the forefront of developing a Covid-19 vaccine. However, Gilead Sciences Inc. said earlier that an analysis showed its antiviral remdesivir helped reduce the risk of death in severely ill COVID-19 patients, but cautioned that rigorous clinical trials were needed to confirm the benefit.

Moreover, BioNTech SE and Pfizer Inc.’s Covid-19 vaccine candidate is expected to be ready to seek regulatory approval by the end of 2020, the Wall Street Journal reported on Friday, citing the German biotech firm’s chief executive officer. The experimental vaccine, which showed promise against the fast-spreading respiratory illness in early-stage human testing, is expected to move into a large trial involving 30,000 healthy participants later this month, pending regulatory nod.

Russia is the first nation to successfully complete the human trials of the corona virus vaccine. It has been many months since the deadly virus shook the world with its intensity. Other countries are also trying their best to find a beneficial solution and put an end to this pandemic. I really hope we can all overcome these testing times and hope for a brighter future.